News & Events
Displaying 1 - 7 of 7
Displaying 1 - 7 of 7
Department of Surgery staff and faculty receive 2022 Chancellor Awards for Diversity
UCSF Department of Surgery
October 27, 2022
UCSF and the Department and Surgery are committed to building a broadly diverse community, nurturing a culture that is welcoming and supportive, and engaging diverse ideas for the provision of culturally competent education, discovery, and patient care. Chancellor Awards for Diversity Chancellor Awards for...
Drs. Robert Warren and Carlos Corvera Awarded Pilot Grant by Collaborative Dedicated to Reducing Health Disparities in Cancer
UCSF Surgical Oncology Program
March 26, 2020
Robert S. Warren, M.D. and Carlos U. Corvera, M.D. are co-Principal Investigators on a pilot grant funded through the University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities collaborative. Comprised of four of the University of...
Rapid Drug Screening with Patient-Derived Organoids to Drive Personalized Medicine
SelectScience.net
January 20, 2020
"In this video, Dr. David Donner, Director of the Surgical Oncology Research Lab at the University of California, San Francisco (UCSF) discusses the research taking place at the Surgical Oncology Research Laboratory at UCSF, and explains how he uses drug dispensing technology* and patient-derived organoids to...
CFCF Awards New Research Grant to Dr. Eric Nakakura to Study Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors
UCSF Surgical Oncology Program
December 13, 2012
Eric Nakakura, M.D., Ph.D. has been awarded the 2012 Caring for Carcinoid Foundation-AACR Grant for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research. Dr. Nakakura will receive $250,000 over two years to understand why some patients develop resistance to mTOR inhibiting drugs like everolimus. In...
Serendipitous Discovery of a Cancer Starter
UCSF Surgical Oncology Program
December 08, 2010
Then post-graduate student Eric Nakakura, M.D., Ph.D., working in the lab of Johns' Hopkins cancer biologist Barry Nelkin, was struck by how the migration of neurological cells to form the developing brain bore an uncanny similarly to the inexorable migration of invasive cells to distant sites in cancer metastasis...
UCSF Scientists Illuminate How microRNAs Drive Tumor Progression
UCSF Surgical Oncology Program
September 16, 2009
UCSF researchers, led by Doug Hanahan, Ph.D., have identified collections of tiny molecules known as microRNAs that affect distinct processes critical for cancer progression. The findings help elucidate the important regulatory function of microRNAs in tumor biology. Eric Nakakura, M.D., Ph.D. (pictured), a...
Surgical & Therapeutic Advances in Pancreatic Cancer
UCSF Surgical Oncology Program
July 15, 2009
For now, the only possible route to outliving pancreas cancer is complete removal of the tumor via surgery. Surgery for pancreas cancer is long and demanding, and surgeons must be practiced to consistently perform it well. Pancreas cancer surgery outcomes are better at high-volume, major medical centers such as...